CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 185 filers reported holding CYTOKINETICS INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,064,284 | +3.2% | 1,224,178 | +14.2% | 0.07% | -3.9% |
| Q2 2023 | $34,953,374 | +4.3% | 1,071,532 | +12.6% | 0.08% | -8.3% |
| Q1 2023 | $33,501,021 | -17.0% | 952,004 | +8.0% | 0.08% | -24.3% |
| Q4 2022 | $40,386,115 | +194.3% | 881,408 | +211.2% | 0.11% | +164.3% |
| Q3 2022 | $13,723,000 | +85.1% | 283,248 | +50.2% | 0.04% | +75.0% |
| Q2 2022 | $7,412,000 | +1539.8% | 188,639 | +1803.3% | 0.02% | +1100.0% |
| Q4 2021 | $452,000 | -65.7% | 9,911 | -73.2% | 0.00% | -60.0% |
| Q3 2021 | $1,319,000 | -63.1% | 36,915 | -77.7% | 0.01% | -80.8% |
| Q3 2020 | $3,579,000 | +2109.3% | 165,298 | +731.6% | 0.03% | +2500.0% |
| Q4 2017 | $162,000 | -98.7% | 19,877 | -97.6% | 0.00% | -97.9% |
| Q3 2017 | $12,209,000 | +59.7% | 841,995 | +33.3% | 0.05% | +50.0% |
| Q2 2017 | $7,645,000 | +17.2% | 631,800 | +24.5% | 0.03% | +6.7% |
| Q1 2017 | $6,521,000 | +64.8% | 507,500 | +55.9% | 0.03% | +42.9% |
| Q4 2016 | $3,956,000 | +217.8% | 325,575 | +84.4% | 0.02% | +200.0% |
| Q1 2016 | $1,245,000 | -48.8% | 176,559 | -24.0% | 0.01% | -58.8% |
| Q4 2015 | $2,431,000 | – | 232,430 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |